Respecting the crucial roles of ATX and LPA2 in cancer progression, evaluating specific miRNAs, which control ATX and LPA2 expression, can be helpful in the development of novel therapeutic strategies for GC patients. This evidence concerns the gene LPAR2 and gastric cancer.